Biofrontera (BFRI) Return on Invested Capital (2021 - 2025)
Biofrontera (BFRI) has 5 years of Return on Invested Capital data on record, last reported at 4.87% in Q3 2025.
- For Q3 2025, Return on Invested Capital rose 718.0% year-over-year to 4.87%; the TTM value through Sep 2025 reached 4.87%, up 718.0%, while the annual FY2024 figure was 2.62%, 148.0% down from the prior year.
- Return on Invested Capital reached 4.87% in Q3 2025 per BFRI's latest filing, down from 7.83% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 18.03% in Q4 2021 and bottomed at 8.04% in Q1 2024.
- Average Return on Invested Capital over 5 years is 0.27%, with a median of 1.55% recorded in 2022.
- Peak YoY movement for Return on Invested Capital: crashed -1872bps in 2022, then skyrocketed 1251bps in 2025.
- A 5-year view of Return on Invested Capital shows it stood at 18.03% in 2021, then tumbled by -104bps to 0.69% in 2022, then crashed by -288bps to 2.68% in 2023, then decreased by -29bps to 3.46% in 2024, then skyrocketed by 241bps to 4.87% in 2025.
- Per Business Quant database, its latest 3 readings for Return on Invested Capital were 4.87% in Q3 2025, 7.83% in Q2 2025, and 6.62% in Q1 2025.